CELU
Price:
$1.973
Market Cap:
$47.46M
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic ...[Read more]
Industry
Biotechnology
IPO Date
2019-08-08
Stock Exchange
NASDAQ
Ticker
CELU
According to Celularity Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 112.66M. This represents a change of -2.22% compared to the average of 115.22M of the last 4 quarters.
The mean historical Enterprise Value of Celularity Inc. over the last ten years is 913.21M. The current 112.66M Enterprise Value has changed 1.13% with respect to the historical average. Over the past ten years (40 quarters), CELU's Enterprise Value was at its highest in in the June 2021 quarter at 1.28B. The Enterprise Value was at its lowest in in the December 2022 quarter at 51.62M.
Average
913.21M
Median
631.23M
Minimum
109.19M
Maximum
3.52B
Discovering the peaks and valleys of Celularity Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 23.76%
Maximum Annual Enterprise Value = 3.52B
Minimum Annual Increase = -77.36%
Minimum Annual Enterprise Value = 109.19M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 113.63M | 4.07% |
| 2023 | 109.19M | -52.96% |
| 2022 | 232.11M | -63.23% |
| 2021 | 631.23M | -36.04% |
| 2020 | 986.90M | 23.76% |
| 2019 | 797.43M | -77.36% |
The current Enterprise Value of Celularity Inc. (CELU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
151.64M
5-year avg
414.61M
10-year avg
913.21M
Celularity Inc.’s Enterprise Value is greater than BioAtla, Inc. (47.72M), greater than Reviva Pharmaceuticals Holdings, Inc. (30.06M), greater than Annovis Bio, Inc. (-17038803690.00), greater than FibroGen, Inc. (103.14M), greater than Actinium Pharmaceuticals, Inc. (-7013958.00), less than BioXcel Therapeutics, Inc. (136.96M), greater than Kezar Life Sciences, Inc. (20.85M), greater than PolyPid Ltd. (31.37M), greater than Tempest Therapeutics, Inc. (9.57M), greater than Generation Bio Co. (71.40M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 47.72M | $49.86M | |
| 30.06M | $40.31M | |
| -17038803690.00 | $91.48M | |
| 103.14M | $33.37M | |
| -7013958.00 | $45.23M | |
| 136.96M | $45.71M | |
| 20.85M | $45.77M | |
| 31.37M | $40.15M | |
| 9.57M | $15.19M | |
| 71.40M | $35.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Celularity Inc.'s Enterprise Value?
What is the highest Enterprise Value for Celularity Inc. (CELU)?
What is the 3-year average Enterprise Value for Celularity Inc. (CELU)?
What is the 5-year average Enterprise Value for Celularity Inc. (CELU)?
How does the current Enterprise Value for Celularity Inc. (CELU) compare to its historical average?